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Introduction 
 
Significant physical sequelae exist for some survivors of a critical illness. There are, however, 
few studies that have examined specific interventions to improve their recovery, and none have 
tested a home-based physical rehabilitation program incorporating trainer visits to participants’ 
homes. This study was designed to test the effect of an individualised 8-week home-based 
physical rehabilitation program on recovery. 
Methods 
 
A multi-centre randomised controlled trial design was used. Adult intensive care patients (length 
of stay of at least 48 hours and mechanically ventilated for 24 hours or more) were recruited from 
12 Australian hospitals between 2005 and 2008. Graded, individualised endurance and strength 
training intervention was prescribed over 8 weeks, with 3 physical trainer home visits, 4 follow- 
up phone calls, and supported by a printed exercise manual. The main outcome measures were 
blinded assessments of physical function; SF-36 physical function (PF) scale and 6-minute walk 
test (6MWT), and health-related quality of life (SF-36) conducted at 1, 8 and 26 weeks after 
hospital discharge. 
Results 
 
Of the 195 participants randomised, 183, 173 and 161 completed the 1, 8 and 26 weeks 
assessments, respectively. Study groups were similar at week 1 post-hospital; for the intervention 
and control groups respectively, mean norm-based PF scores were 27 and 29 and the 6MWT 
distance was 291 and 324 metres. Both groups experienced significant and clinically important 
improvements in PF scores and 6MWT distance at 8 weeks, which persisted at 26 weeks. Mixed 
model analysis showed no significant group effects (p=0.84) or group by time interactions 
(p=0.68) for PF. Similar results were found for 6MWT and the SF-36 summary scores. 
Conclusions 
 
This individualised 8-week home-based physical rehabilitation program did not increase the 
underlying rate of recovery in this sample, with both groups of critically ill survivors improving 
their physical function over the 26 weeks of follow-up. Further research should explore 
improving effectiveness of the intervention by increasing exercise intensity and frequency, and 
identifying individuals who would benefit most from this intervention. 
 
 
 
Trial registration 
 
Australian and New Zealand Clinical Trials Register ACTRN12605000166673 
Introduction  
 
 
A critical illness requiring admission to a general intensive care unit (ICU) affects approximately 
 
119,000 adult Australians per year.[1] While survival rates approximate 89% at hospital 
discharge, [2] functional recovery for individuals is delayed often beyond six months post- 
discharge. [3, 4] Physical de-conditioning and neuromuscular dysfunction [5, 6] as well as 
psychological sequelae [7] are common, adding to the burden of illness for survivors, carers, the 
health care system and broader society.[8] 
 
Reviews of numerous observational studies confirm delayed recovery in health-related quality of 
life (HRQOL),[e.g. 3, 4, 9] and anxiety (12-43%),[10] depression (median 28%) [11] and distress 
(including post-traumatic stress symptoms; 5-64%)[12] are prevalent. While significant sequelae 
therefore exist for a substantial proportion of critical illness survivors, little evidence is currently 
available to support specific interventions for improving their recovery, [8, 13] with very few 
published interventional studies focusing on the post-hospital discharge period; e.g. follow-up 
clinics,[14] a patient self-managed rehabilitation manual.[15] No studies have tested the effects 
of home-based rehabilitation involving trainer visits on patient recovery. 
 
 
We proposed that a focused home-based approach to physical rehabilitation in addition to usual 
community-based health services, would improve the HRQOL and recovery of individuals 
surviving a critical illness. The rehabilitation program for this cohort reflected similar successful 
programs in cardiac and respiratory disease [16, 17] by optimising functional recovery, 
particularly during the first few months after a critical illness. 
Materials and methods  
 
 
Design, hypothesis and secondary aims 
 
 
A multi-centre randomised controlled trial (RCT) design was used to test the effects of an eight- 
week home-based rehabilitation program on HRQoL and physical function for individuals who 
survived a critical illness. The primary research hypothesis was: Survivors of a critical illness 
who participated in the physical rehabilitation program have better physical function, as 
measured by a difference of 10 points on the Physical Functioning (PF) scale of the Short- 
Form-36 Health Survey (SF-36), when compared to those who received usual care at eight 
 
weeks after hospital discharge (short-term effect); and that this group difference would persist at 
 
26 weeks (long-term effect). Secondary aims were to test the program effectiveness for: 
improvement in other domains of HRQOL (Component Summary scores of SF-36[18]); and 
better functional exercise capacity, measured by the six-minute walk test (6MWT) [19]. 
 
The study protocol was published previously [20] and the flow of participants reflects the 
CONSORT statement.[21] Human Research Ethics Committee approvals were obtained from 
each of the recruitment site hospitals and the universities of the investigators. A safety protocol 
ensured assessor and trainer safety during home visits.[20] 
 
Participants  and sample size 
 
 
Participants were initially recruited from ICUs in Sydney and Brisbane (4 teaching and 3 
district hospitals) with other recruitment sites added progressively from Sydney and Perth (2 
teaching, 2 district and 1 private hospital). Sample size was calculated for the SF-36 PF scale 
for a two-sided hypothesis test with a Type I error rate of 0.05 and a Type II error rate of 0.20 
 (80% power). The clinically important difference and the standard deviation estimates used 
were based on our pilot data [22, 23] and reports for similar cohorts and contexts.[15, 24-26] 
 
At baseline (1 week post-hospital discharge), we anticipated that both groups would have mean 
PF scores of 45. We postulated that the control group would improve by 5 points at 8 weeks, 
with the intervention group improving by 15 points, giving a difference of 10 points between 
the two study groups using the traditional non-normalised raw score for SF-36. Using the 10 
items that comprise the PF scale of SF-36, this improvement represents a change from ‘limited 
a lot’ to ‘limited a little’ on three items in the scale, for example in climbing stairs or walking 
particular distances. These changes reflect significant clinical improvement in physical 
function.[27] 
 
A sample of 100 patients per study group was required to detect this difference, assuming similar 
group variance (SD=25). [22, 28] We planned to over-enrol by 20% to account for losses to 
follow-up (10% study attrition;[15] 10% mortality at 6-months post-hospital discharge following 
a critical illness).[1, 29] The total planned recruitment was therefore 240. 
 
To be eligible for enrolment, participants: 1) were aged 18 years or older; 2) had an ICU length of 
stay (LOS) of ≥ 48 hours; 3) received mechanical ventilation for ≥ 24; 4) were discharged home 
to self-care or carer (non-institutional care); 5) resided within the hospitals’ local geographical 
areas to enable home visits (approximately 50 km radius); 6) had no neurological, spinal or 
skeletal dysfunction preventing participation in physical rehabilitation; 7) were not receiving 
palliative care; 8) had no organised rehabilitation related to ongoing chronic disease management 
(e.g. pulmonary rehabilitation, cardiac rehabilitation); and 9) were cognitively able to complete 
the self-report measures and comply with physical testing instructions. 
 Randomisation 
 
 
Eligible patients were approached following ICU discharge; informed voluntary consent was 
either obtained at that time or following agreement to be contacted at home after hospital 
discharge. After participant consent, the site project officer contacted an independent telephone 
randomisation service for the participant study number and group allocation. The service used a 
blocked random allocation sequences (one for each recruitment site) generated using SAS 
software[30] by our study statistician (MK). 
 
Intervention 
 
 
Participants in the control group received usual community-based care after hospital discharge 
(e.g. visits to their general practitioner), as well as the three study assessment visits, but no other 
placebo or sham interventions. Following the first home-based assessment, participants 
randomised to the intervention group received an 8-week home-based physical rehabilitation 
program that focused on strength training and walking. A qualified trainer (physiotherapist, 
exercise physiologist or registered nurse with additional specific training for this project) visited 
participants at home in weeks 1, 3 and 6 to provide individualised verbal and written instructions 
on their planned exercise program. Each home visit session was 60-90 minutes in duration. The 
trainer also telephoned intervention group participants in weeks 2, 4, 5 and 7 to monitor their 
progress. 
 
The program reflected standard approaches for improving muscle strength and endurance within 
cardiac and pulmonary rehabilitation settings.[31, 32] Exercise prescription and supervised 
physical rehabilitation training involved graded, individualised endurance and strength training 
designed by a pulmonary rehabilitation physiotherapist. Training focused initially on walking 
(endurance training) and lower limb exercises (strength training). As participants progressed, core 
 stabilisation and upper limb exercises were introduced. The remaining 2 trainer home visits and 
telephone contacts in non-visit weeks assessed participant progress and compliance, prescribed 
progression and reinforced the exercise program.[20] 
 
An illustrated exercise manual supported the participant’s training and graded progression, 
structured in 3 parts: Part 1 described how to gauge exercise intensity based on a level of 
‘moderate’ to ‘somewhat heavy’ perceived exertion (score of 3-4 on the modified Borg Scale) 
[33] and also provided information about participant safety; Part 2 provided a detailed exercise 
program; and Part 3 described how to progress the endurance and strength training. The exercise 
program consisted of 5 components – endurance exercise (walking), lower and upper limb 
strengthening, core stabilisation, flexibility, and stretches. A total of 16 different exercises were 
numbered, named, illustrated and described, to facilitate participant-trainer communication and 
exercise progression. This included four stretching, three flexion, and three core stabilisation 
exercises, which were included in the trainer’s exercise prescription based on assessment of the 
participant’s capabilities and needs. 
 
Endurance (walk) training 
 
 
Exercise prescription for endurance training was based on the results of each participant’s 6MWT 
during the week 1 assessment visit. Training intensity commenced at 80% of peak walking speed. 
Extra activities were prescribed based on a level of perceived exertion of 3-4 using the modified 
Borg scale.[33] A walk-rest-walk approach was used, with the duration of walking varying 
according to the participant’s ability and condition; 12 levels of walking were described ranging 
from 1-60 minutes. Participants worked towards an optimal goal of training for 5 days per week 
for 20-30 minutes of walking by the end of the program. 
 Strength training 
 
 
This training included upper (biceps, triceps, shoulder abductors/adductors) and lower limb 
(quadriceps, hamstrings, hip abductors and extensors) muscle groups. Initial prescription was one 
set of eight-repetition maximum (8RM) for each activity, progressing to three sets. Further 
progression was based on increasing weight (0.25 – 1.5 kg for arm exercises using cans of food 
or bags of rice), and increasing the step height or weight for lower limb exercises. Levels of 
progression were described in the exercise manual. 
 
Outcomes 
 
 
Each participant was assessed in-home within one week of hospital discharge by an assessor 
blind to group allocation, with follow-up assessments at 8 and 26 weeks post-discharge. The 
primary outcome measure was the physical functioning of study participants, using the SF-36 PF 
scale (version 2).[18] SF-36 has demonstrated reliability, validity and responsiveness in the post- 
ICU population, [34] and is the most common instrument used for assessing health status in this 
patient cohort.[3, 4, 8, 9] 
 
Secondary outcome measures were exercise capacity measured using the 6MWT; [19] and 
HRQOL. The 6MWT was performed twice at each assessment, to account for any learning effect, 
with the best result recorded for analysis. During the 6MWT, participants were directly observed 
and monitored continuously by the assessor using a portable pulse oximeter (measuring pulse rate 
and oxygen saturation), with their exertion level assessed and documented during the test [19] 
using the Borg perceived exertion scale. [33] Additional aspects of HRQOL were measured using 
the Physical Component Summary (PCS) and Mental Component Summary (MCS) scales, which 
combine information from all eight domains of SF-36.[18] 
 Statistical methods 
 
Data were entered into a purpose-built MS Access database at the 3 coordinating sites; monthly 
site reports on enrolment, randomisation and participant follow-up were submitted to one central 
site and monthly summaries of the whole cohort reviewed by our team. Analysis was by 
intention-to-treat, and was conducted for the primary outcome (SF-36 physical functioning; PF) 
and three secondary outcomes, the 6MWT distance, the physical component summary (PCS) and 
the mental component summary (MCS) scores of SF-36. The SF-36 scales (PF, PCS and MCS) 
were calculated as per the user’s manual.[18] The eight raw domain scores were transformed to a 
score range of 0-100 (a higher score represents better functioning / HRQOL). Domain scores 
were then further summarised into PCS and MCS scores using z-scores with each domain mean 
and standard deviation derived from Australian normative data.[35, 36] The component aggregate 
score was calculated by summing the weighted z-scores using factor score coefficients from 
normative population data as weight. The aggregate component scores and the PF domain z-score 
were then converted to norm-based scores (NBS) as: NBS = 50 + (z-score x 10).[36] Norm-based 
scores are interpreted in relation to the population mean of 50 and a standard deviation of 10. 
Baseline characteristics of both groups were described in terms of percentages for categorical 
variables and mean and standard deviation for continuous variables. 
 
Study hypotheses were tested with mixed linear regression models estimated by residual 
maximum likelihood using SAS Proc Mixed.[30] Fixed effects were estimated for randomisation 
group (to test for differences between groups at 8 weeks), time (to test for change from 8 to 26 
weeks), and a group by time interaction (to test for differences in change by group), with the 
baseline level of the outcome variable included as a covariate. Each model included a random 
person specific intercept to account for within person correlation. Patient characteristics 
 considered to be potential confounders (age, gender, APACHE II scores, days in ICU, days in 
hospital) and site were included as covariates. Covariates were retained if: 1) there was evidence 
of confounding (estimates of treatment effect differed markedly between adjusted versus 
unadjusted models); 2) they explained significant variation in the outcome; 3) they improved the 
precision of the estimates of treatment effect. The F-test was used to test for the significance of 
effects and the adjusted mean levels of each outcome variable were calculated for each group at 8 
and 26 weeks (adjusted for baseline levels). As a secondary descriptive analysis, individual 
change scores were calculated between baseline (week 1 post-hospital discharge) and at 8 and 26 
weeks. Within-group effect size was calculated as mean change from baseline/standard deviation 
at baseline, and between-group effect size was calculated as the difference between groups in 
mean change from baseline divided by the pooled standard deviation for change.[37] 
 
 
 
 
Results 
 
Study recruitment occurred from June 2005 – August 2008, with final follow-up data collection 
completed in February 2009. Of the 5,980 patients screened, 5,655 were excluded; the main 
reasons were excessive distance from the study sites precluding home visits, neurological or 
spinal dysfunction precluding physical training, and palliative care / not expected to survive ICU 
admission (Figure 1). Of the 195 patients randomised during their post-ICU hospitalisation, 93% 
provided primary outcome data at week 1 post-hospital discharge. Their subsequent response rate 
was 95% (97% control and 92% intervention) at 8 weeks and 88% (93% of control and 85% of 
intervention) at 26 weeks. Eleven patients died and 16 withdrew during the study period (Figure 
1). 
 Characteristics for the intervention and control groups were similar at baseline (Table 1). The 
mean age of the sample was 57 years, and 61% were male. Both groups had a median ICU length 
of stay of 6 days and median hospital length of stay of 18.5 days. The overall median period of 
mechanical ventilation was 90 hours, with a mean Day 1 APACHE II score of 19.5. Fifty-five 
percent of participants had a non-operative diagnosis. The most prevalent APACHE III 
diagnostic groups on admission were gastrointestinal (30%), respiratory (24%) and 
cardiovascular (20%), with 8% sepsis and 6% trauma diagnoses. The baseline (week 1) mean 
norm-based PF scores were 27.1 and 28.8 for the intervention and control groups respectively, 
and the 6MWT distance was 291 and 324 metres (Table 1). Physical functioning at baseline did 
not differ significantly between those with complete and incomplete data (p=0.86). 
There were no significant group effects or group by time interactions (see Table 2) for PF, and no 
significant covariates after adjusting for baseline PF. This was also the case for 6MWT, MCS and 
PCS (Table 2). Other domains for SF-36 were also comparable between groups at all time points 
(Table 4 details the domain scores for the two groups). The time effect was significant for PF 
(p=0.034) and 6MWT (p=0.0003), but not for PCS (p=0.06) or MCS (p=0.97).  Both control and 
intervention groups showed similar improvements between week 1 and week 8, and week 1 and 
week 26 for the PF and 6MWT, and the PCS and MCS (see Table 3). Clinically important change 
scores of 12 (control) and 13 (intervention) for the mean PF were noted at 8 weeks. The change 
scores between weeks 1 to 26 were 14 and 15 respectively, with little additional improvement 
from the 8 week assessment. Change scores for 6MWT distance were 80 and 89 metres at 8 
weeks, and 116 and 126 metres at 26 weeks, for the control and intervention groups respectively 
(Table 3). Effect sizes for the impact of the intervention were very small for all measures at 8 and 
26 weeks (Table 3), consistent with the mixed linear regression models (Table 2). 
  
 
 
Discussion 
 
 
Major findings 
 
 
Our main findings were that this home-based rehabilitation intervention had no significant effect 
on physical recovery and functional status, when compared to significant improvements over 
time, particularly during the first 8 weeks post-hospital discharge. Both groups improved their 
physical endurance and HRQOL with a similar trajectory at 8 and 26 weeks. 
 
Possible reasons for lack of difference between the groups were: 1) Natural recovery in this cohort 
overwhelmed any differences afforded by training; 2) Lack of compliance by intervention group 
participants, as exercise training was unsupervised except for 3 occasions during the 8 weeks; 3) 
Prospective measurement of the control group at 8 and 26 weeks may have influenced outcomes 
by encouraging participation in exercise; 4) Training intensity was not adequate, although this was 
unlikely given that this was individualised, based on 6MWT results and progressed as able. Even 
at 8 weeks the 6MWD was only approximately 408 metres suggesting that using 6MWD as a way 
of prescribing intensity was still adequate. Had the 6MWD been near to predicted normal (600m) 
this might have suggested that other means of exercise training where intensity could be higher 
e.g. running, treadmill exercise, would have been required. Some of these issues are discussed in 
the ‘study limitations’ below. 
 
This sample of survivors of a critical illness was broadly representative of the 83,000 patients 
admitted to public-sector general adult ICUs in Australia each year, in terms of APACHE II score 
(19.5 vs 15) and mechanical ventilation hours (91 vs 71), with our study inclusion criteria of ≥ 48 
hours of ICU admission and ≥ 24 hours of mechanical ventilation probably accounting for these 
 differences. (An additional 36,000 adults are admitted to ICUs in private hospitals but their 
clinical profile is different [APACHE II = 13; median mechanical ventilation hours = 44; ICU 
mortality = 2.7% vs 7.5%][1]). The mortality rate for study participants at 6 months was 6% 
(11/183), within our a priori expectations of 10%, although we have no data on those participants 
who withdrew prior to (n = 12) or after the week 1 assessment (n = 16) or were lost to follow-up 
(n = 7). 
 
A recent systematic review[38] of 53 observational studies noted decreased HRQOL in survivors 
of a critical illness compared to age and gender-matched populations. In relation to other 
intervention studies from the United Kingdom, our participants at week 1 and week 26 were 
remarkably similar to a recent equivalent randomised clinical trial of nurse-led ICU follow-up 
clinics in 3 hospitals (median age = 57 years; 60% males; APACHE II = 19; ICU LOS was 
higher in our study, 6 vs. 3 days; mechanical ventilation hours not reported).[14] Their 
intervention also included a manual-based, self-directed physical rehabilitation program from in- 
hospital to 3 months post-hospital discharge, and clinic appointments at 3 and 9 months. The PCS 
at week 1 was 32 in our study, compared to 33 (n=286) in the U.K. study. At week 26, the PCS in 
our study was 43, compared to 40 (n=220). Interestingly, this trial also did not demonstrate an 
intervention effect, and noted the possible reasons for this null finding as an ineffective 
intervention package, timing of the first intervention, no account for cognitive factors that may 
influence recovery, or too broad an inclusion criteria (particularly in relation to ICU LOS).[14] 
 
In contrast, an earlier study of a 6-week self-help rehabilitation manual with phone follow-up 
compared to usual care (ward visits, 3 post-discharge phone-calls, and ICU follow-up clinics at 8 
weeks and 6 months), demonstrated an effect on the PF at 6 months; scores for the control and 
intervention groups were 40 and 50 respectively (n = 44 and 58).[15] These scores for the control 
 group were again similar to our findings of approximately 42 for both groups. Only modest 
improvements on the PF were also noted from 8 weeks to 6 months,[15] again similar to our 
findings from 8 to 26 weeks. Neither of these two studies assessed walk function. 
 
Overall, participants from both the control and intervention groups improved their 6MWT 
distance by 27% at 8 weeks and 39% at 26 weeks from the week 1 assessments. These 
improvements of 89 and 120 metres compared favourably with increases from pulmonary 
rehabilitation programs for patients with moderate-severe lung disease (35 metres; 10% 
improvement)[17] and diffuse lung disease (34 metres).[39] In an observational study of ARDS 
patients (n=109), a median 6MWT distance of 396 metres at 6 months (n=78; APACHE II = 23; 
ICU LOS = 25 days; mechanical ventilation = 21 days) compared favourably to the 430 metres in 
our sample of less sick patients.[40] 
 
The 8 week intervention of 3 home visits for at least 1 hour of supervised training, 4 telephone 
follow-ups, and an expected 2-3 unsupervised participant training sessions per week for the 8- 
week program was consistent with studies of COPD patients.[41, 42] Recent clinical practice 
guidelines recommend high-intensity aerobic training (60-80% of peak effort) and strength 
training for COPD patients.[43] 
 
A small RCT of early physical therapy in ICU in combination with daily interruption of sedation 
demonstrated that the intervention group participants were 2.7 times more likely to return to 
independent functional status at hospital discharge. Median walking distance at hospital 
discharge for the intervention group (n=49) was 33 metres (range 0-91m), compared to 0 metres 
(0-30m) for the control group (n=55).[44] Findings from a current single-site randomised study 
of a post-ICU and outpatient clinic rehabilitation program is anticipated to add further 
 understanding to the effect of these types of interventions on function across the continuum of 
recovery.[45] 
 
A recent systematic review of 12 RCTs of cardiac rehabilitation noted superior adherence to a 
home-based program, with centre-based programs having sub-optimal participation because of 
access, dislike of groups and other commitments.[16] However, others have noted that an 
individually tailored exercise level was not sufficient to influence functional outcomes in 
hospitalised acute medical patients aged 65 years or older.[46] 
 
The burden for survivors of a critical illness has been well documented in many observational 
studies, where the recovery trajectory is often prolonged and sub-optimal.[4] Intervention studies 
with this clinical cohort are however less common. To our knowledge this was the first study 
internationally to use a home-based rehabilitation program with trainer visits in this patient 
group. An individualised, home-based program negates the need to attend an outpatient clinic 
located in a hospital on a regular basis. This is particularly important for individuals who reside 
in regional or rural areas but were treated in a metropolitan ICU, as well as those who choose not 
to or are unable to participate in hospital-based programs for other reasons such as lack of 
mobility. The provision of a program through local community health services would allow 
survivors of a critical illness to engage in the program regardless of place of residence and other 
mobility and access constraints. 
 
Study limitations 
 
 
A number of limitations are noted. Although based on previous equivalent work,[15] our 
hypothesised treatment ‘effect’ of a 10-point difference in the PF was optimistic, with no 
clinically or functionally important differences noted between groups at either post-intervention 
measurement; both groups improved by an average 12 points at 8 weeks (not 5 and 15 points for 
 the control and intervention groups, respectively). Effectiveness of the rehabilitation program 
may be improved by increasing the intensity, frequency and training support, but this requires 
further investigation, particularly in relation to participant safety in a home-based context. 
Importantly and similar to an earlier study, [14] our collective knowledge of physical 
rehabilitation in this cohort has advanced significantly since we designed our intervention, 
including a recent focus on in-ICU mobility. e.g. [47-50] 
 
Our target recruitment sample of 240 was not achieved despite screening almost 6000 patients 
over 39 months, including a 12-month extension of the project from the grant funding body and 
inclusion of additional recruitment sites (recruitment ceased because of timeframe and funding 
constraints). Our screening data noted a significant proportion (28%) of patients admitted to the 
city-based recruitment ICUs resided outside metropolitan areas. Following analysis, and as noted 
above, the effect size and resulting sample size calculations were too small. 
 
As detailed in Figure 1, large numbers of patients were excluded from this study. Approximately 
half of these exclusions were due to the patient not being suitable for rehabilitation (e.g. palliative 
care), or having a condition that required different rehabilitation (e.g. neurological dysfunction or 
cardiac disease where rehabilitation was provided). Some of the exclusions were the result of 
limitations of a research setting (e.g. living too far away from a study hospital), and these 
individuals living distant from tertiary level hospitals could benefit if an effective intervention is 
able to be identified. 
 
The three assessment visits for the control group were additional to ‘usual care’. While this 
contact was unavoidable and may have had a placebo effect, any effect would reduce the 
apparent effectiveness of the intervention. The treatment effect was therefore measured relative to 
the control group in the study, while in practice the comparator would be usual care without 
 assessment contact. Measurement of physical activity in a trial can also influence participant 
behaviour.[51] We have no way of knowing how participants in our control group responded to 
their 6MWT assessments, possibly changing their physical activity behaviour. 
 
We were unable to objectively assess the compliance of training for the intervention group, and 
relied on self-reports of participants during trainer home visits and follow-up phone calls. Finally, 
given that we demonstrated no added effectiveness from the intervention compared to the control, 
the lack of an economic evaluation was of no practical consequence. 
 
Implications for practice 
 
 
From a practice perspective, the benefits of a systematic approach and equitable access to post- 
ICU rehabilitation services remains unclear for facilitating the recovery of survivors to their 
optimal physical, psychological and social function. While not demonstrating effectiveness of the 
intervention, actual delivery of this home-based program was feasible for participants and 
trainers. If an effective intervention can be identified, then using a home-based approach may be 
of value for some individuals unable to attend hospital outpatient clinics because of location, 
travel limitations or other reasons. 
 
Recommendations for future research 
 
 
Future research should explore strategies to increase the effect size of any proposed intervention, 
and implement appropriate screening processes to identify individuals who would benefit most 
from a rehabilitation program; that is those with demonstrated functional weakness or 
impairment. 
 Conclusions 
 
 
This study used a multi-centre randomised controlled trial design to examine the efficacy of a 
novel application of physical rehabilitation practices to an important but often heterogeneous 
group of patients – survivors of a critical illness. The study addressed outcomes that are 
meaningful for patients and society – functional ability and well-being following a critical illness, 
and also targeted a health problem that is likely to increase as the population ages, contributing to 
an area in which there are currently minimal rigorous intervention studies. 
 
While these null findings noted no significant effect on physical recovery when compared to 
improvement over time, the results do provide a baseline to further develop and test interventions 
aimed at improving the recovery trajectories for survivors of a critical illness. 
 
 
 
 
Key messages 
 
• Reviews of observational studies confirm significant physical and psychological sequelae 
for a substantial proportion of critical illness survivors 
• There are mixed findings from the limited number of intervention studies that tested the 
effectiveness of physical rehabilitation programs for survivors of a critical illness, and no 
studies have tested a home-based program using trainer visits 
• This study demonstrated that a home-based physical rehabilitation program was no more 
effective than usual care in improving physical function or health-related quality of life 
for survivors of a critical illness at 6 months following hospital discharge 
• Further work is required to improve the effect of any interventions for survivors of a 
critical illness 
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 Table 1: Sample baseline characteristics 
 
Variable  Control 
(n= 91) 
Intervention 
(n= 92) 
Age mean (sd) 57.5 (15.1) 57.2 (17.0) 
Gender %  M: 61  M: 62 
APACHE II mean (sd) 19.5 (7.2) 19.4 (12.6) 
MV hours mean (sd) 135 (117)  142 (159) 
median c (IQR) 91 (48-179) 76 (41-180) 
ICU LOS days mean (sd)    8.6 (7.5)  9.4 (8.7) 
median (IQR) 6 (4-10.5) 6 (4-11) 
Hospital LOS 
days 
mean (sd) 23.2 (16.9) 24.8 (20.4) 
 
median (IQR) 18.5 (12-27.5) 18.5 (12-30) 
SF-36 PF a mean (sd) 28.8 (10.2) 27.1 (12.3) 
 
6MWT distance 
metres a 
mean (sd) 324 (143) 291 (129) 
SF-36 PCS b mean (sd)  32.7 (8.6) 31.7 (10.0) 
SF-36 MCS b mean (sd) 39.8 (13.5) 36.7 (15.1) 
 
APACHE = acute physiology and chronic health evaluation; MV = mechanical ventilation hours; 
LOS = length of stay; PCS = physical components summary; MCS = mental components 
summary. 
 
a  Measured at 1 week post-hospital discharge 
b   Norm-based score; Australian normative population mean = 50; standard deviation = 10 
c Medians included only for those variables with skewed distributions 
 Table 2 Mixed linear regression model: mean outcomes adjusted for week 1 (baseline) 
levels 
 
Outcome  Week  Control Treatment p-value 
Physical Functioning 8 41.0 39.9 Group 0.84 
 26 41.8 42.6 Time 0.034 
Group x time 0.68 
6 Minute Walk Test 8 395.6 402.5 Group 0.92 
distance  
26 
 
431.4 
 
428.3 
 
Time 
 
0.0003 
Group x time 0.55 
Physical Component 8 42.5 40.7 Group 0.39 
Summary  
26 
 
43.2 
 
42.7 
 
Time 
 
0.06 
Group x time 0.37 
Mental Component 8 47.1 46.9 Group 0.95 
Summary  
26 
 
47.0 
 
47.0 
 
Time 
 
0.97 
Group x time 0.89 
 
 
 
Table 3 Mean change from baseline and effect size at 8 and 26 weeks following 
discharge 
 
 Control 
(95%CI) 
Effect 
Sizea 
Intervention 
(95%CI) 
Effect 
Sizea 
Difference 
(95%CI) 
Effect 
Sizeb 
8 weeks 
PFd 
 
12.2 (9.9,14.5) 
 
1.17 
 
12.9 (10.7,15.1) 
 
1.02 
 
0.7 (-2.5,3.8) 
 
0.07 
6MWT 80.3 (52.3,108.3) 0.55 88.7 (62.6,114.8) 0.69 8.4 (-29.6, 46.4) 0.07 
PCSc 9.9 (7.6,12.2) 1.10 8.6 (6.6,10.5) 0.87 -1.3 (-4.3, 1.7) -0.14 
MCSc 7.8 (4.8,10.9) 0.59 9.7 (6.4,12.9) 0.66 1.8 (-2.6, 6.2) 0.13 
26 weeks      
PF
 
13.7 (11.4,16.0)
 
1.32
 
14.6 (11.7,17.6)
 
1.16
 
0.9 (-2.7, 4.6)
 
0.08
 
6MWT 116.2 (85.6,146.8) 0.80 125.8 (98.7,152.9) 0.98 9.6 (-31.4, 50.5) 0.08 
PCSc 10.6 (8.4,12.8) 1.18 10.9 (8.2,13.6) 1.11 0.3 (-3.2, 3.7) 0.03 
MCSc 8.1 (5.0,11.2) 0.61 9.6 (6.1,13.1) 0.65 1.5 (-3.1, 6.2) 0.10 
 
CI = confidence interval, PF = physical functioning, 6MWT = 6 minute walk test distance 
(metres), PCS = physical component summary, MCS = mental component summary. 
 
a Effect size=mean change from baseline/standard deviation at baseline 
b Effect size=(Intervention mean change-Control mean change)/ pooled standard deviation for 
change 
c Norm-based score for Australian normative population mean=50, standard deviation=10. 
 Table 4 Mean norm-baseda SF-36 scores by assessment time point and group 
 
SF-36 Domains  Week 1 Week 8 Week 26 
 Groups C I C I C I 
Physical Function
 
29.1
 
27.3
 
41.0
 
39.9
 
41.8
 
42.6
 
Role Function - Physical 25.5 25.1 38.0 38.2 40.9 42.1 
Bodily Pain 43.0 38.7 49.0 46.7 46.9 44.5 
General Health 43.5 41.7 46.0 44.7 45.3 44.8 
Vitality 38.1 36.0 46.9 45.5 47.0 47.6 
Social Function 30.1 27.9 44.9 43.0 44.5 44.5 
Role Function – Emotional 32.0 28.0 42.4 41.1 42.9 43.6 
Mental Health 43.4 40.1 48.2 48.0 48.1 48.4 
Physical Component Summary 33.0 31.6 42.7 40.5 42.9 42.8 
Mental Component Summary 40.0 36.6 47.5 46.9 47.2 48.0 
 
C = control, I = intervention. 
 
a Norm-based scores for domain and summary scores are calculated from raw scores using 
population-based data for the Australian population; scores are interpreted in relation to a 
population mean of 50 and a standard deviation of 10. 
 
 
 
Figure 1 : Consort  flow diagram of patient  recruitment and retention 
   
Week 1 (baseline)  assessment 
Responded  (n=92) 
Withdrawal  (n=3) 
Lost to follow-up (n=1) 
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